Enzymes such as tissue plasminogen activator (tPA), streptokinase, and urokinase-type plasminogen activator (uPA) serve as therapeutic treatments to inhibit coagulation in instances of acute myocardial infarctions or small cerebral thrombi [72]. The gene discussed is PLAT; the disease is myocardial infarction.